Use of alendronate in peri-implant defect regeneration

Journal of Periodontology

Volumn 70, Issue 2, 1999, Pages 151-158

  Meraw, Stephen J ^a   Reeve, Charles M ^a   Wollan, Peter C ^b  

^a MAYO CLINIC   (United States)

^b Department of Dental Specialties ^*

Author keywords

Alendronate therapeutic use; Animal studies; Bone regeneration; Dental implants; Hydroxyapatite; Osseointegration

Indexed keywords

ALENDRONIC ACID; HYDROXYAPATITE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE REGENERATION; BONE REMODELING; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; FLUORESCENCE ANALYSIS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PERIODONTICS; TOOTH IMPLANTATION; TOPICAL DRUG ADMINISTRATION;

ALENDRONATE; ANIMALS; BONE REGENERATION; COATED MATERIALS, BIOCOMPATIBLE; COLLAGEN; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL PROSTHESIS DESIGN; DOGS; DURAPATITE; FLUORESCENT DYES; GUIDED TISSUE REGENERATION, PERIODONTAL; IMAGE PROCESSING, COMPUTER-ASSISTED; MANDIBLE; MEMBRANES, ARTIFICIAL; OSSEOINTEGRATION; OSTEOGENESIS; SURFACE PROPERTIES; TITANIUM;

EID: 0033039059     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.2.151     Document Type: Article

References (26)

1. Adell R, Lekholm U, Rockler B, Brånemark PI. A 15-year study of osseointegrated implants in the treatment of the edentulous jaw. Int J Oral Surg 1981; 10:387-416.
2. Albrektsson TA. Bone tissue response. In: Brånemark PI, Zarb GA, Albrektsson TA, eds. Tissue-Integrated Prostheses, Osseointegration in Clinical Dentistry. Chicago: Quintessence; 1985:6.
3. Kirsch A, Ackerman K. The IMZ osteointegrated implant system. Dent Clin North Am 1989;33:733-791.
4. Albrektsson T, Lekholm U. Osseointegration: Current state of the art. Dent Clin North Am 1989;33:537-554.
5. Lekholm U, Zarb GA. Patient selection and preparation. In: Brånemark PI, Zarb GA, Albrektsson TA, eds. Tissue-Integrated Prostheses, Osseointegration in Clinical Dentistry. Chicago: Quintessence; 1985:12.
6. Misch CE. Density of bone: Effect on treatment plans, surgical approach, healing, and progressive bone loading. Int J Oral Implantol 1990;6:23-31.
7. Spiekermann H. Implantology. New York: Thieme Medical Publishers; 1995:317-328.
8. Brånemark PI, Hansson B, Adell R, et al. Osseointegrated oral implants in the rehabilitation of the edentulous patient. Experience from a 10-year period. Scand J Plast Reconstr Surg 1977;11 (suppl. 16): 1-132.
9. Buser D, Dula K, Belser U, Hirt HP, Berthold H. Localized ridge augmentation using guided bone regeneration. 1. Surgical procedure in the maxilla. Int J Periodontics Restorative Dent 1993;13:29-45.
10. Dahlin C, Sennerby L, Lekholm U, Linde A, Nyman S. Generation of new bone around titanium implants using a membrane technique: An experimental study in rabbits. Int J Oral Maxillofac Implants 1989;4:19-25.
11. Becker W, Becker BE. Guided tissue regeneration for implants placed into extraction sockets and for implant dehiscences: Surgical techniques and case report. Int J Periodontics Restorative Dent 1990;10:376-391.
12. Hurley LA, Stinchfield FE, Bassett AL, Lyon WH. The role of soft tissues in osteogenesis: An experimental study of canine spine fusions. J Bone Joint Surg 1959;41A:1243-1254.
13. The American Academy of Periodontology. The potential role of growth and differentiation factors in periodontal regeneration. J Periodontol 1996;67:545-553.
14. Reddy MS, Weatherford TW, Smith CA, West BD, Jeffcoat MK, Jacks TM. Alendronate treatment of naturally occurring periodontitis in beagle dogs. J Periodontol 1995;66:211-217.
15. Jung A, Van Ouwenaller C, Chantraine A, Courvoisier B. Parental disphosphonates for treating malignant hypercalcemia. Cancer 1981;48:1922-1925.
16. O'Doherty DP, Gertz BJ, Tindale W, Sciberras DG, Survill TT, Kanis JA. Effects of five daily 1 hour infusions of alendronate in Paget's disease of bone. J Bone Miner Res 1992;7:81-87.
17. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73-79.
18. Liberman UA, Weiss SR, Broll J, et al. Effects of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995;333:1437-1443.
19. Weinreb M, Quartuccio H, Seedor JG, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodont Res 1994;29:35-40.
20. Denissen H, van Beek E, Lowik C, Papapoulos S, van den Hooff A. Ceramic hydroxyapatite implants for the release of bisphosphonate. Bone Miner 1994;25:123-134.
21. Tsuchimoto M, Azuma Y, Higuchi O, et al. Alendronate modulates osteogenesis of human osteoblastic cells in vitro. Jpn J Pharmacol 1994;66:25-33.
22. Rohrer MD, Schubert CC. The cutting-grinding technique for histologic preparation of undecalcified bone and bone-anchored implants. Oral Surg Oral Med Oral Pathol 1992;74:73-78.
23. Becker W, Lynch SE, Lekholm U, et al. A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-1 or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants. J Periodontol 1992;63:929-940.
24. Compston JE, Vedi S, Stellon AJ. Inter-observer and intra-observer variation in bone histomorphometry. Calc Tissue Int 1986;38(2):67-70.
25. De Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med 1996;335:1016-1021.
26. Padilla JL. A Comparison Between Endosseous Brånemark Implants and a Prototype Implant in Dogs. [Thesis]. Rochester, MN: Mayo Graduate School; 1996. 94 p.